Skip to content
Disclosery

Decheng Capital Management III (Cayman), LLC

Follow

13F filer, CIK 1747821, Grand Cayman, Cayman Islands

Decheng Capital Management III (Cayman), LLC reported $267,206,983 across 26 holdings for the quarter ended 2022-12-31, in a 13F-HR filed 2023-02-09. Its ten largest share positions make up 80.22% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-23-017522

Period
2022-12-31
Reported value
$267M
Holdings
26
Top 10 weight
80.22%
New
2
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
Alabama Power 5.20% Div Qua…new+6,708,288$49.3M
BeyondSpring Inc.new+4,958,143$9.32M
AURAadded+83,333$875K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ALPINE IMMUNE SCIENCES INCexited-6,708,288-$48.3M
ILMNreduced-49,279-$9.96M
BYSIexited-4,958,143-$4.91M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2022

Share positions as resolved from 13F-HR 0001104659-23-017522, largest first. % of portfolio is the value over $267,206,983, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
Alabama Power 5.20% Div Qua…Alabama Power 5.20% Div QualifQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 6,708,288 shares 6,708,288$49.3M18.45%new
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: 1,824,583 shares; 2022Q3: 1,824,583 shares; 2022Q4: 1,824,583 shares 1,824,583$36.7M13.75%0Timeline
PROMETHEUS BIOSCIENCES INCPROMETHEUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 250,000 shares; 2022Q2: 250,000 shares; 2022Q3: 250,000 shares; 2022Q4: 250,000 shares 250,000$27.5M10.29%0
HLTHQCUE HEALTH INC COM (DE)Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 8,980,909 shares; 2022Q2: 8,980,909 shares; 2022Q3: 8,980,909 shares; 2022Q4: 8,980,909 shares 8,980,909$18.6M6.96%0Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 869,790 shares; 2022Q2: 869,790 shares; 2022Q3: 869,790 shares; 2022Q4: 869,790 shares 869,790$18M6.73%0Timeline
ILMNILLUMINA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 154,238 shares; 2022Q2: 154,238 shares; 2022Q3: 130,138 shares; 2022Q4: 80,859 shares 80,859$16.3M6.12%-49,279Timeline
ALBIREO PHARMA INCALBIREO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 518,342 shares; 2022Q2: 518,342 shares; 2022Q3: 623,342 shares; 2022Q4: 623,342 shares 623,342$13.5M5.04%0
TXG10X GENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 303,984 shares; 2022Q2: 303,984 shares; 2022Q3: 359,554 shares; 2022Q4: 359,554 shares 359,554$13.1M4.9%0Timeline
PACBPACIFIC BIOSCIENCES CALIF INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 1,463,872 shares; 2022Q2: 1,463,872 shares; 2022Q3: 1,463,872 shares; 2022Q4: 1,463,872 shares 1,463,872$12M4.48%0Timeline
BeyondSpring Inc.BeyondSpring Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 4,958,143 shares 4,958,143$9.32M3.49%new
HORIZON THERAPEUTICS PLCHORIZON THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: 55,400 shares; 2022Q3: 78,900 shares; 2022Q4: 78,900 shares 78,900$8.98M3.36%0
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 714,285 shares; 2022Q2: 714,285 shares; 2022Q3: 714,285 shares; 2022Q4: 714,285 shares 714,285$7.27M2.72%0Timeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 526,329 shares; 2022Q2: 526,329 shares; 2022Q3: 526,329 shares; 2022Q4: 526,329 shares 526,329$6.75M2.53%0Timeline
Mersana Therapeutics IncMersana Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 904,268 shares; 2022Q2: 904,268 shares; 2022Q3: 904,268 shares; 2022Q4: 904,268 shares 904,268$5.3M1.98%0
ADICET BIO INCADICET BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 580,000 shares; 2022Q2: 580,000 shares; 2022Q3: 580,000 shares; 2022Q4: 580,000 shares 580,000$5.19M1.94%0
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 4,447,308 shares; 2022Q2: 4,447,308 shares; 2022Q3: 4,447,308 shares; 2022Q4: 4,447,308 shares 4,447,308$4.89M1.83%0Timeline
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 210,000 shares; 2022Q2: 210,000 shares; 2022Q3: 210,000 shares; 2022Q4: 293,333 shares 293,333$3.08M1.15%+83,333Timeline
SEATTLE GENETICS INCSEATTLE GENETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: 23,014 shares; 2022Q4: 23,014 shares 23,014$2.96M1.11%0
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: 5,529 shares; 2022Q4: 5,529 shares 5,529$2.09M0.78%0Timeline
AtriCure Inc.AtriCure Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 46,259 shares; 2022Q2: 46,259 shares; 2022Q3: 46,259 shares; 2022Q4: 46,259 shares 46,259$2.05M0.77%0
Pyxis Oncology, Inc (former…Pyxis Oncology, Inc (formerly Ape…Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: 1,894,551 shares; 2022Q4: 1,894,551 shares 1,894,551$1.29M0.48%0
SEMA4 HOLDINGS CORPSEMA4 HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 3,418,929 shares; 2022Q2: 3,418,929 shares; 2022Q3: 3,418,929 shares; 2022Q4: 3,418,929 shares 3,418,929$903K0.34%0
SCYXSCYNEXIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 555,555 shares; 2022Q2: 555,555 shares; 2022Q3: 555,555 shares; 2022Q4: 555,555 shares 555,555$867K0.32%0Timeline
NAUTNAUTILUS BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 300,000 shares; 2022Q2: 300,000 shares; 2022Q3: 300,000 shares; 2022Q4: 300,000 shares 300,000$540K0.2%0Timeline
OWLET INCOWLET INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 898,400 shares; 2022Q2: 898,400 shares; 2022Q3: 898,400 shares; 2022Q4: 898,400 shares 898,400$502K0.19%0
Ohr Pharmaceutical IncOhr Pharmaceutical IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 1,000,000 shares; 2022Q2: 1,000,000 shares; 2022Q3: 1,000,000 shares; 2022Q4: 1,000,000 shares 1,000,000$190K0.07%0

Sold out in Q4 2022

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ALPINE IMMUNE SCIENCES INCALPINE IMMUNE SCIENCES INC6,708,288$48.3Mshares
BYSIBEYONDSPRING INC4,958,143$4.91Mshares

How Q4 2022 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-23-017522 base2023-02-09acceptance time not in the bulk data set